Healthcare & Life Science

Penta

Penta Diet is a leading Italian company specializing in personalized ketogenic diets tailored to a variety of medical conditions, primarily obesity, diabetes, metabolic syndrome, and migraines. In addition, the company has developed a wide range of protein-based products, which can be integrated into its dietary programs and are sold online.

Orienta Capital Partners, an investment firm specializing in club deals and private investments, was identified as the ideal partner. The transaction was structured as a leveraged buyout, with the founder retaining a 30% stake in the company.

Cross Border assisted the shareholders in identifying a financial partner capable of supporting the company’s growth through industry expertise, managerial capabilities, and e-commerce know-how. Cross Border managed the entire transaction process as exclusive financial advisor, from identifying and selecting potential investors, to preparing marketing materials and investor documentation, and ultimately supporting Penta Diet throughout the transaction structuring, due diligence, and negotiation phases.